biomarkers

An innovative device decentralizes blood collection and unlocks a new horizon for blood-based biomarker discovery.

From ancient medicines to equipping humans with new senses, tattoos are more than just permanent marks on the skin. They may boost immune function, and they have the potential to effectively deliver therapeutics through the skin.

What do 23andMe and Snapchat have in common? They both collect very personal information about their users. Do the benefits outweigh the risks?

Through academic, industry, and governmental partnerships, scientists validate and develop non-invasive diagnostics for non-alcoholic fatty liver disease. These tests are set to replace the invasive and risky gold standard: liver biopsy.

LIVE March 29th, 2022 at 2:30 PM
Proteolysis targeting chimeras (PROTACs) are promising agents for developing novel anticancer drugs.

A bioengineer mines the biometric data from smartwatches and smartphones to find digital biomarkers for respiratory infections like COVID-19.

Researchers are tapping into the regenerative power of stem cells to treat central nervous system disorders.

LIVE September 13th, 2021 at 11:00 AM ET
In this webinar, Shane Needham will discuss methods to optimize protein quantification workflows and introduce a new HRAMS system, the ZenoTOF 7600.   

High tumor mutation burden can predict immunotherapy response only in subset of cancers

NuView’s theranostics approach could make cancer diagnosis and treatment more affordable